IMAFLEX INC Operating Income Over Time
| 6YS Stock | 1.42 0.01 0.70% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out IMAFLEX INC Performance and IMAFLEX INC Correlation. IMAFLEX |
Cross Equities Operating Income Analysis
Compare IMAFLEX INC and related stocks such as ROCHE HLDG, Abbott Laboratories, and DANAHER (DAPSG) Operating Income Over Time
| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RHO | 14.1 B | 14.1 B | 14.1 B | 14.1 B | 14.1 B | 14.1 B | 14.1 B | 13 B | 14.7 B | 17.5 B | 18.5 B | 18.2 B | 17.5 B | 15.4 B | 13.4 B | 18.5 B | 17.7 B |
| ABL | 3.2 B | 3.2 B | 3.2 B | 3.2 B | 3.2 B | 3.2 B | 3.2 B | 1.7 B | 3.6 B | 4.5 B | 5.4 B | 8.4 B | 8.4 B | 6.5 B | 6.8 B | 8.1 B | 6.2 B |
| DAP | 2.8 B | 2.8 B | 2.8 B | 2.8 B | 2.8 B | 2.8 B | 2.8 B | 3 B | 3.4 B | 3.3 B | 4.2 B | 6.4 B | 7.5 B | 5.2 B | 4.9 B | 4.7 B | 5 B |
| QCI | 6.5 B | 6.5 B | 6.5 B | 6.5 B | 6.5 B | 6.5 B | 2.6 B | 742 M | 7.7 B | 6.3 B | 9.8 B | 15.9 B | 8.7 B | 10.3 B | 12.4 B | 14.3 B | 8.9 B |
| 6MK | 6 B | 6 B | 6 B | 6 B | 6 B | 6 B | 6 B | 7.3 B | 8.9 B | 12.2 B | 5.5 B | 13.2 B | 18.3 B | 3 B | 20.2 B | 22.1 B | 12.9 B |
| NOT | 8.3 B | 8.3 B | 8.3 B | 8.3 B | 8.3 B | 8.3 B | 8.3 B | 8.6 B | 8.2 B | 9.1 B | 10.2 B | 10.1 B | 7.9 B | 9.8 B | 14.5 B | 17.6 B | 11.5 B |
| NOT | 11.1 B | 11.1 B | 11.1 B | 11.1 B | 11.1 B | 9 B | 8.3 B | 8.6 B | 8.2 B | 9.1 B | 10.2 B | 10.1 B | 7.9 B | 9.8 B | 14.5 B | 17.6 B | 11.4 B |
| AMD | (382 M) | (382 M) | (382 M) | (382 M) | (382 M) | (382 M) | (382 M) | 204 M | 451 M | 631 M | 1.4 B | 3.6 B | 1.3 B | 401 M | 2.1 B | 3.7 B | 3.9 B |
| 4I1 | 10.8 B | 10.8 B | 10.8 B | 10.8 B | 10.8 B | 10.8 B | 10.8 B | 11.5 B | 11.3 B | 10.4 B | 11.6 B | 13 B | 12.2 B | 12.2 B | 13.4 B | 14.9 B | 13.4 B |
| W8V | 220 B | 220 B | 220 B | 220 B | 220 B | 220 B | 220 B | 220 B | 220 B | 220 B | 220 B | 220 B | 220 B | 220 B | 220 B | 198 B | 176 B |
IMAFLEX INC and related stocks such as ROCHE HLDG, Abbott Laboratories, and DANAHER (DAPSG) Operating Income description
Operating Income is the amount of profit realized from IMAFLEX INC operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of IMAFLEX INC is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| IMAFLEX INC | 6YS |
Specialization | Consumer Cyclical, Packaging & Containers |
| Business Address | 5710 Notre-Dame Street |
| Exchange | Frankfurt Exchange |
null 1.42
Other Information on Investing in IMAFLEX Stock
IMAFLEX INC financial ratios help investors to determine whether IMAFLEX Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in IMAFLEX with respect to the benefits of owning IMAFLEX INC security.